AVDL
Avadel Pharmaceuticals plc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$21.64
+0.00%Jul 31, 2026, 00:00 UTC
Vistagen Therapeutics appointed Douglas J. Williamson, M.D. as a director, effective July 29, 2026, with stock option compensation and eligibility for the Director Compensation Plan.
Jun 19, 2026, 19:49 UTC
Alkermes plc acquired Avadel Pharmaceuticals to bolster its hypersomnolence portfolio with LUMRYZ.
Source: